|
|
The Cryocare CS incorporates enhanced control mechanisms to minimize the risk of unintended damage to tissue surrounding the prostate. The argon gas-based cryoprobes stop freezing instantly. During cryotherapy procedures, six to eight temperature probes are selectively placed in the prostate near the rectal tissue, sphincter muscles that control continence, and neurovascular bundles that control potency. These temperature probes enable the physician to monitor temperatures of tissue adjacent to the prostate in real-time.
|